These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15284729)

  • 1. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
    Chaiworapongsa T; Romero R; Espinoza J; Bujold E; Mee Kim Y; Gonçalves LF; Gomez R; Edwin S
    Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].
    Zou CL; Liu XH; Yue BM; Fu JH; He GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
    Tripathi R; Rath G; Jain A; Salhan S
    Ann Anat; 2008 Nov; 190(5):477-89. PubMed ID: 18992679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors.
    Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Koide K; Okazaki S; Nakamura M; Okai T
    Am J Obstet Gynecol; 2008 Jan; 198(1):124.e1-7. PubMed ID: 18166325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calprotectin plasma level is elevated in preeclampsia.
    Holthe MR; Staff AC; Berge LN; Fagerhol MK; Lyberg T
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):151-4. PubMed ID: 15683375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia.
    Kwon JY; Maeng YS; Kwon YG; Kim YH; Kang MH; Park YW
    Gynecol Obstet Invest; 2007; 64(2):103-8. PubMed ID: 17339774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
    Chaiworapongsa T; Espinoza J; Gotsch F; Kim YM; Kim GJ; Goncalves LF; Edwin S; Kusanovic JP; Erez O; Than NG; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):25-40. PubMed ID: 18175242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.
    Koga K; Osuga Y; Yoshino O; Hirota Y; Ruimeng X; Hirata T; Takeda S; Yano T; Tsutsumi O; Taketani Y
    J Clin Endocrinol Metab; 2003 May; 88(5):2348-51. PubMed ID: 12727995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.
    Oron G; Ben-Haroush A; Hod M; Orvieto R; Bar J
    Obstet Gynecol; 2006 Apr; 107(4):896-900. PubMed ID: 16582129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
    Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
    McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
    Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.